Trial Profile
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2024
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Antineoplastics
- Indications Advanced breast cancer; Early breast cancer; Male breast cancer
- Focus Biomarker; Pharmacodynamics
- 15 Mar 2024 Planned End Date changed from 31 Aug 2024 to 31 Aug 2025.
- 15 Mar 2024 Planned primary completion date changed from 31 Aug 2024 to 31 Aug 2025.
- 14 Mar 2023 Planned End Date changed from 31 Aug 2023 to 31 Aug 2024.